Novo Nordisk settles US patent fight with Viatris over Ozempic, …
WEB17 hours ago · Oct 7 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab and Viatris (VTRS.O), opens new tab have agreed to resolve a patent dispute over Novo's blockbuster weight-loss drugs Ozempic and Wegovy ...
Novo Nordisk CEO testifies at Senate over weight loss drug prices
WEBSep 24, 2024 · Novo Nordisk ’s top executive faced a Senate grilling on Tuesday over the high prices of the company’s weight loss drug Wegovy and diabetes treatment Ozempic, as demand for both injections soars...
Latest news - Novo Nordisk
WEBAug 6, 2024 · Latest news. 20 September 2024. Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed. Read more. 19 September 2024. Novo Nordisk A/S: Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function. Read more. 06 …
Company announcements and press releases - Novo Nordisk
WEBEuropean regulatory authority adopts a positive opinion for an update of the Wegovy® label to reflect risk reduction of major adverse cardiovascular events. Novo Nordisk receives Complete Response Letter in the US for once-weekly basal insulin icodec.
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy …
WEBApr 20, 2024 · Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss drugs, but the Danish company has far bigger ambitions.
Novo Nordisk expects double-digit growth as it boosts Wegovy …
WEBCOPENHAGEN/LONDON, Jan 31 (Reuters) - Novo Nordisk on Wednesday forecast another year of double-digit growth as the Danish drugmaker began boosting U.S. supplies of its popular weight-loss drug...
Novo Nordisk to build $4.1 billion North Carolina facility to boost ...
WEBJun 24, 2024 · Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug Wegovy,...
How Ozempic and Wegovy turned Novo Nordisk into a $400 …
WEBOct 10, 2023 · Danish drugmaker Novo Nordisk has entered a new chapter in its 100-year history — thanks to its newfound success with two products: Ozempic and Wegovy. The drugs are once-weekly injectables of...
Ozempic and Wegovy maker faces scrutiny over high costs of …
WEBSep 24, 2024 · The chief executive of the drugmaker Novo Nordisk, Lars Fruergaard Jørgensen, is scheduled to face tough questions Tuesday on Capitol Hill about the high costs of the company’s widely popular ...
News Details - Novo Nordisk
WEBMar 5, 2024 · Novo Nordisk A/S: Semaglutide 1.0 mg demonstrates 24% reduction in the risk of kidney disease-related events in people with type 2 diabetes and chronic kidney disease in the FLOW trial. Bagsværd, Denmark, 5 March 2024 – Novo Nordisk today announced the headline results from the kidney outcomes trial FLOW.